Mycoplasma pneumoniae from the respiratory tract and beyond

KB Waites, L Xiao, Y Liu, MF Balish… - Clinical microbiology …, 2017 - Am Soc Microbiol
Mycoplasma pneumoniae is an important cause of respiratory tract infections in children as
well as adults that can range in severity from mild to life-threatening. Over the past several …

Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus

DM Musher, MS Abers, JG Bartlett - Clinical Infectious Diseases, 2017 - academic.oup.com
Before 1945, Streptococcus pneumoniae caused more than 90% of cases of pneumonia in
adults. After 1950, the proportion of pneumonia caused by pneumococcus began to decline …

Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality

JA Ramirez, TL Wiemken, P Peyrani… - Clinical Infectious …, 2017 - academic.oup.com
Background Understanding the burden of community-acquired pneumonia (CAP) is critical
to allocate resources for prevention, management, and research. The objectives of this study …

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label …

NJ Brendish, AK Malachira, L Armstrong… - The Lancet …, 2017 - thelancet.com
Background Respiratory virus infection is a common cause of hospitalisation in adults.
Rapid point-of-care testing (POCT) for respiratory viruses might improve clinical care by …

Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia

WH Self, RA Balk, CG Grijalva… - Clinical Infectious …, 2017 - academic.oup.com
Background. Recent trials suggest procalcitonin-based guidelines can reduce antibiotic use
for respiratory infections. However, the accuracy of procalcitonin to discriminate between …

Advances in the causes and management of community acquired pneumonia in adults

RG Wunderink, G Waterer - Bmj, 2017 - bmj.com
Community acquired pneumonia remains a common cause of morbidity and mortality.
Usually, the causal organism is not identified and treatment remains empiric. Recent …

Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre …

M Suzuki, BG Dhoubhadel, T Ishifuji… - The Lancet infectious …, 2017 - thelancet.com
Background The serotype-specific effectiveness of 23-valent pneumococcal polysaccharide
vaccine (PPV23) against pneumococcal pneumonia has not been established in people …

Rapid tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review and meta-analysis

AHL Bruning, MMG Leeflang, JMBW Vos… - Clinical Infectious …, 2017 - academic.oup.com
Rapid diagnosis of respiratory virus infections contributes to patient care. This systematic
review evaluates the diagnostic accuracy of rapid tests for the detection of respiratory …

Additional molecular testing of saliva specimens improves the detection of respiratory viruses

KKW To, L Lu, CCY Yip, RWS Poon… - Emerging Microbes & …, 2017 - Taylor & Francis
Emerging infectious diseases in humans are often caused by respiratory viruses such as
pandemic or avian influenza viruses and novel coronaviruses. Microbiological testing for …

CKD and risk for hospitalization with infection: the atherosclerosis risk in communities (ARIC) study

J Ishigami, ME Grams, AR Chang, JJ Carrero… - American Journal of …, 2017 - Elsevier
Background Individuals on dialysis therapy have a high risk for infection, but risk for infection
in earlier stages of chronic kidney disease has not been comprehensively described. Study …